Similarly, treatment with IgG 2A11 resulted in lower levels of HMGB1 in the tumor extracts of the mice treated with IgG 2A11 than in the mice treated with the control IgGs (p < 0.001). This evidence concerns the gene HMGB1 and neoplasm.